These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

354 related items for PubMed ID: 17503749

  • 1. Evaluation of cytomegalovirus DNAaemia versus pp65-antigenaemia cutoff for guiding preemptive therapy in transplant recipients: a randomized study.
    Gerna G, Baldanti F, Torsellini M, Minoli L, Viganò M, Oggionnis T, Rampino T, Castiglioni B, Goglio A, Colledan M, Mammana C, Nozza F, Daniele L, Bergamo Transplant Group.
    Antivir Ther; 2007; 12(1):63-72. PubMed ID: 17503749
    [Abstract] [Full Text] [Related]

  • 2. Human cytomegalovirus pp67 mRNAemia versus pp65 antigenemia for guiding preemptive therapy in heart and lung transplant recipients: a prospective, randomized, controlled, open-label trial.
    Gerna G, Baldanti F, Lilleri D, Parea M, Torsellini M, Castiglioni B, Vitulo P, Pellegrini C, Viganò M, Grossi P, Revello MG.
    Transplantation; 2003 Apr 15; 75(7):1012-9. PubMed ID: 12698090
    [Abstract] [Full Text] [Related]

  • 3. Clinically-based determination of safe DNAemia cutoff levels for preemptive therapy or human cytomegalovirus infections in solid organ and hematopoietic stem cell transplant recipients.
    Lilleri D, Baldanti F, Gatti M, Rovida F, Dossena L, De Grazia S, Torsellini M, Gerna G.
    J Med Virol; 2004 Jul 15; 73(3):412-8. PubMed ID: 15170637
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Validation of a DNAemia cutoff for preemptive therapy of cytomegalovirus infection in adult hematopoietic stem cell transplant recipients.
    Gerna G, Lilleri D, Caldera D, Furione M, Zenone Bragotti L, Alessandrino EP.
    Bone Marrow Transplant; 2008 May 15; 41(10):873-9. PubMed ID: 18209721
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Comparison of antigenemia assay and semiquantitative polymerase chain reaction test for monitoring active cytomegalovirus infection in allogeneic hematopoietic cell transplant recipients.
    Pajand O, Ziyaeyan M, Mousavi S, Fatolahzadeh B, Hojabri Z, Bahador A, Abdossamadi Z.
    Exp Clin Transplant; 2008 Jun 15; 6(2):149-54. PubMed ID: 18816243
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Bronchiolitis obliterans syndrome and early human cytomegalovirus DNAaemia dynamics after lung transplantation.
    Westall GP, Michaelides A, Williams TJ, Snell GI, Kotsimbos TC.
    Transplantation; 2003 Jun 27; 75(12):2064-8. PubMed ID: 12829913
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Quantitative analysis of HCMV DNA load in whole blood of renal transplant patients using real-time PCR assay.
    Gouarin S, Vabret A, Gault E, Petitjean J, Regeasse A, Hurault de Ligny B, Freymuth F.
    J Clin Virol; 2004 Mar 27; 29(3):194-201. PubMed ID: 14962789
    [Abstract] [Full Text] [Related]

  • 12. Long-term renal graft function and survival in patients with high-risk for cytomegalovirus infection receiving preemptive therapy.
    Alberú J, Morales-Buenrostro LE, Correa-Rotter R, Muñoz-Trejo T, Zúñiga-Varga J, Cuéllar-González JV, Mayorga-Madrigal H, Vanegas-Carrero R, Aranda F, Rodríguez-Romo R, Herrera-Garcia C, González-Michaca L, Sierra-Madero JG.
    Rev Invest Clin; 2008 Mar 27; 60(5):365-74. PubMed ID: 19227433
    [Abstract] [Full Text] [Related]

  • 13. Saliva as a source of HCMV DNA in allogeneic stem cell transplantation patients.
    Correia-Silva JF, Bruna-Romero O, Resende RG, Miranda LP, Oliveira FE, Costa FO, Xavier SG, Figueiredo-Neves SP, Almeida HC, Bittencourt H, Gomez RS.
    Oral Dis; 2010 Mar 27; 16(2):210-6. PubMed ID: 20374507
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The impact of early cytomegalovirus infection and disease in renal transplant recipients.
    Sagedal S, Hartmann A, Rollag H.
    Clin Microbiol Infect; 2005 Jul 27; 11(7):518-30. PubMed ID: 15966969
    [Abstract] [Full Text] [Related]

  • 18. HCMV pp67-mRNA detection by nucleic acid sequence-based amplification in renal transplant patients.
    Merlino C, Bergallo M, Gregori G, Sinesi F, Bollero C, Cavallo R.
    New Microbiol; 2002 Jan 27; 25(1):1-8. PubMed ID: 11837384
    [Abstract] [Full Text] [Related]

  • 19. [pp65 antigenemia in evaluation of cytomegalovirus infection after kidney transplantation].
    Orlić P, Dvornik S, Husnjak SC, Aralica M, Orlić L, Zivcić-Cosić S, Sladoje-Martinović B, Fućak M.
    Acta Med Croatica; 2003 Jan 27; 57(1):49-52. PubMed ID: 12876863
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.